Ildstad S - Search Results

1

Addition of a bone marrow "facilitating cell" population increases stem cell-derived cobblestone area formation in impaired long-term bone marrow culture stroma.

Yaroslavskiy B, Colson Y, Ildstad S, Parrish D, Boggs SS. Yaroslavskiy B, et al. Among authors: ildstad s. Exp Hematol. 1998 Jul;26(7):604-11. Exp Hematol. 1998. PMID: 9657135

2

Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.

Gaines BA, Colson YL, Kaufman CL, Ildstad S. Gaines BA, et al. Among authors: ildstad s. Exp Hematol. 1996 Jul;24(8):902-13. Exp Hematol. 1996. PMID: 8690049

3

Xenotransplantation: Strategies to Achieve Donor-specific Tolerance and Immune Reconstitution Across Species Barriers Through Mixed Bone Marrow Chimerism.

Gammie JS, Kaufman CL, Michaels MG, Ildstad ST. Gammie JS, et al. Mol Diagn. 1996 Sep;1(3):219-224. doi: 10.1016/s1084-8592(96)70005-x. Mol Diagn. 1996. PMID: 10462563

4

Donor-specific tolerance induction in composite tissue allografts.

Foster RD, Fan L, Neipp M, Kaufman C, McCalmont T, Ascher N, Ildstad S, Anthony JP, Niepp M. Foster RD, et al. Among authors: ildstad s. Am J Surg. 1998 Nov;176(5):418-21. doi: 10.1016/s0002-9610(98)00248-7. Am J Surg. 1998. PMID: 9874425

5

Current progress in chimerism and donor-specific tolerance.

Jankowski RA, Ildstad ST. Jankowski RA, et al. Among authors: ildstad st. Transplant Proc. 1996 Aug;28(4):2071-4. Transplant Proc. 1996. PMID: 8769159 Review. No abstract available.

6

Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.

Jankowski RA, Ildstad ST. Jankowski RA, et al. Among authors: ildstad st. Hum Immunol. 1997 Feb;52(2):155-61. doi: 10.1016/S0198-8859(96)00290-X. Hum Immunol. 1997. PMID: 9077564 Review.

7

HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation.

Senev A, Tambur AR, Kosmoliaptsis V, Copley HC, García-Sánchez C, Usenko C, Ildstad ST, Leventhal JR. Senev A, et al. Among authors: ildstad st. Front Immunol. 2024 Mar 27;15:1377535. doi: 10.3389/fimmu.2024.1377535. eCollection 2024. Front Immunol. 2024. PMID: 38601147 Free PMC article.

8

Immune tolerance via FCR001 cell therapy compared with maintenance immunosuppression for kidney transplantation: Real-world evidence analysis of safety and efficacy.

Krieger N, Chodoff L, Leventhal JR, Ho B, Richards M, Schaumberg DA, Laidlaw D, Ildstad ST, Axelrod DA. Krieger N, et al. Among authors: ildstad st. Clin Transplant. 2023 Nov;37(11):e15074. doi: 10.1111/ctr.15074. Epub 2023 Aug 3. Clin Transplant. 2023. PMID: 37534547

9

Evaluation of Immunocompetence and Biomarkers of Tolerance in Chimeric and Immunosuppression-free Kidney Allograft Recipients.

Leventhal JR, Galvin J, Ison MG, Feng CY, Ding R, Lee JR, Li C, Mathew JM, Gallon L, Gibson M, Belshe D, Tollerud DJ, Gornstein E, Suthanthiran M, Ildstad ST. Leventhal JR, et al. Among authors: ildstad st. Transplantation. 2023 Oct 1;107(10):e257-e268. doi: 10.1097/TP.0000000000004666. Epub 2023 Sep 25. Transplantation. 2023. PMID: 37370204

10

The Potential Clinical Application of Induced Tolerogenic Macrophages.

Xu H, Suire C, Ildstad ST. Xu H, et al. Among authors: ildstad st. Transplantation. 2023 Jan 1;107(1):23-24. doi: 10.1097/TP.0000000000004246. Epub 2022 Jul 25. Transplantation. 2023. PMID: 35876367 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters